CM-101
CM-101-SC-001
Phase 1 small_molecule completed
Quick answer
CM-101 for Nonalcoholic Steatohepatitis (NASH) is a Phase 1 program (small_molecule) at Chemomab Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chemomab Therapeutics
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed